Welcome investment in UK life sciences by Quintiles

Yesterday afternoon I attended the opening of the European headquarters of Quintiles, one of the world’s largest clinical research organisations, in Reading, UK.

Page Content

It is great to see Quintiles making the most of the UK’s strong science heritage, world-class scientists and leading academics. Their new UK-based headquarters was opened by Chairman and CEO Dennis Gillings, CBE, with a supportive quote read out from Parliamentary Under-Secretary of State for Health Lord Howe.

The new facility highlights Quintiles' recognition of the importance of Europe – and especially the UK – to the life sciences. The location of their new headquarters is a clear statement of belief in the UK’s ability to deliver in this area.

This is a huge investment in the UK by a leading biopharmaceutical company – their investment presents us with the opportunity to dispel some of the myths and incorrect perceptions about the UK research environment.

Quintiles has shown that they believe the UK is able to deliver on clinical trials throughout Europe from Phase I through to launch. This is a significant statement which recognises the important work of the National Institute for Health Research and others to ensure that the UK is seen as a leader in research and development (R&D). We have made significant progress working together, and the Government’s ‘Plan for Growth’ announced earlier this year recognised the valuable contribution to be made by R&D into the health and wealth agenda.

We hope this investment by Quintiles will persuade other decision-makers in the pharmaceutical industry to follow suit and direct more clinical research in UK and Europe. The UK is most certainly open for business.

Get in touch

I am happy for ABPI to keep my details on file and to send me details of future ABPI work and services. ABPI will not sell your data to any third party or send you any information about products or services that ABPI has no direct connection with.

The Association of the British Pharmaceutical Industry

is a company limited by guarantee registered in England and Wales
(registered number 09826787) and its registered office is at
7th Floor Southside,105 Victoria Street, London, SW1E 6QT.
Telephone +44 (0) 207 9303477

The Prescription Medicines Code of Practice Authority (PMCPA) was established by The Association of the British Pharmaceutical Industry to operate the ABPI Code of Practice for the Pharmaceutical Industry independently of the ABPI. The PMCPA is a division of ABPI which is a company registered in England and Wales (registered number 09826787) with its registered office at 7th Floor, Southside, 105 Victoria Street, London SW1E 6QT.

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 7th Floor Southside, 105 Victoria Street, London, SW1E 6QT. OHE provides independent research, advisory and consultancy services on policy implications and economic issues within the pharmaceutical, health care and biotechnology sectors.